Literature DB >> 14637071

Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease.

John G Nutt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14637071     DOI： 10.1016/s0014-4886(03)00304-2

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  4 in total

1.  The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.

Authors:  Orazio Schillaci; Mariangela Pierantozzi; Luca Filippi; Carlo Manni; Livia Brusa; Roberta Danieli; Giorgio Bernardi; Giovanni Simonetti; Paolo Stanzione
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-08       Impact factor: 9.236

Review 2.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

3.  Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease.

Authors:  D Devos; P Krystkowiak; F Clement; K Dujardin; O Cottencin; N Waucquier; K Ajebbar; B Thielemans; M Kroumova; A Duhamel; A Destée; R Bordet; L Defebvre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

4.  Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Authors:  K S Rommelfanger; G L Edwards; K G Freeman; L C Liles; G W Miller; D Weinshenker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.